跳至主要内容
临床试验/NCT04406480
NCT04406480Unknown不适用

Contribution of the Exome Sequencing in Antenatal Period Behind Ultrasound Features Suggestive of a Rare Genetic Disease

University Hospital, Strasbourg, France23 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年8月5日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
90
试验地点
23
主要终点
Diagnostic contribution of the exome sequencing in antenatal period in comparison with the chromosomal analysis (CGH-array) realized in current health care

研究概览

简要总结

Congenital malformations concern 3% of pregnancies; most of them can be seen during pregnancy. For some malformations, an invasive sample (trophoblast biopsy or amniocentesis) is proposed to search a chromosomal abnormality by the technique of DNA chip. However, some strongly suggestive signs of a genetic (and not chromosomal) pathology have a very low diagnostic rate with this technique. In the absence of an etiological diagnosis, the prognosis for the unborn child is very difficult to assess, as we can't know if the fetal malformation is really isolated or associted to other unseen features as part of a syndromic condition.

For some malformations strongly suggestive of a genetic condition, we propose to realize an exome (i.e. all coding parts of the genome) sequencing of the trio (child and the 2 parents) with a delivery time compatible with the emergency situation of a pregnancy (6 weeks maximum). We will apply bioinformatics filters to analyse only genes known to be involved in the malformation present in the unborn child and thus avoid the identification of variants in unrelated genes. These lists of genes have been previously validated by the Rare Disease Health Sectors and the affiliated diagnostic laboratories. The selected malformations are: 1) anomalies of the central nervous system (microcephaly (<- 2DS) with anomalies of gyration, anomalies of the posterior fossa, anomalies of the midline except agenesis of the corpus callosum), 2) ophthalmological anomalies (microphthalmia, hyperplasia vitreous) and 3) renal abnormalities (large hyperechoic kidneys).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Father and mother of an unborn child past the age of majority
  • Consent dated and signed by the mother and by the father
  • Father and mother able to understand the objectives and risks of the study
  • For the mother, pregnancy in progress (between 12 and 34 weeks)
  • For the mother, pregnancy with the presence of a malformation on ultrasound, confirmed by a doctor from the multidisciplinary diagnostic prenatal center, entering into the indications retained for this study
  • Clinical validation of the couple's eligibility by an expert for some of selected indications
  • Father and mother affiliated to a social protection health

排除标准

  • Identified genetic or chromosomal abnormality explaining the observed malformation
  • Inability to give informations to the father and / or mother (father or mother in emergency or life-threatening situation)
  • Father and / or mother under the protection of justice
  • Father and / or mother under guardianship or curatorship
  • Nursing woman

结局指标

主要结局

Diagnostic contribution of the exome sequencing in antenatal period in comparison with the chromosomal analysis (CGH-array) realized in current health care

时间窗: 13 months

Comparison of the number of genetic diagnoses made by exome sequencing and by CGH-array.

次要结局

  • Feasibility study of carrying out exome sequencing in the antenatal period in terms of time to deliver results(13 months)
  • Effects on pregnancy management and/or postnatal child care due to an etiological diagnosis(13 months)

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验